Schedule 13G ownership disclosure

N/A

Security class unavailable · CUSIP: 01345P106

Event date: 2022-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,362,484
Percent of class
6.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001740053-23-000002
Form type
SC 13G
Filer
ALBIREO PHARMA, INC.
CIK
CIK 1322505
Filed
Jan 23, 2023
Reporting period
Dec 31, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub